Cineverse (CNVS) Stock Chart & Stock Price History → This 1 Biotech Stock has been shocking the markets (From Huge Alerts) (Ad) Free CNVS Stock Alerts $0.83 0.00 (0.00%) (As of 05/8/2024 ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Cineverse Stock Price Performance5 Day Performance+0.59%1 Month Performance-41.13%3 Month Performance-41.96%6 Month Performance-28.45%Year-To-Date Performance-38.52% Receive CNVS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Cineverse and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Priority GoldThe 2024 Gold Rush: Unleashing Market PotentialWelcome to the financial rollercoaster of 2024, where inflation is persistent, stock markets are overinflated and volatile, global conflicts are intensifying, and the national debt is reaching new heights.Get your free information kit NOW, before it's too late. CNVS Stock Chart for Thursday, May, 9, 2024 CNVS Chart by TradingView Cineverse Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/08/2024$0.83$0.83$0.84$0.8263,601 shs$11.06 million05/07/2024$0.81$0.83+1.88%$0.86$0.80127,141 shs$11.06 million05/06/2024$0.83$0.81-1.26%$0.83$0.78171,437 shs$10.86 million05/03/2024$0.79$0.83+4.13%$0.84$0.7957,384 shs$11.00 million05/02/2024$0.79$0.79+0.94%$0.83$0.79141,419 shs$10.56 million05/01/2024$0.80$0.79-1.86%$0.83$0.78134,815 shs$10.46 million Get the Latest News and Ratings for CNVS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Cineverse and its competitors with MarketBeat's FREE daily newsletter. 04/30/2024$0.82$0.80-2.94%$0.86$0.7862,924 shs$10.66 million04/29/2024$0.85$0.82-3.04%$0.86$0.8276,533 shs$10.99 million04/26/2024$0.83$0.85+2.29%$0.87$0.8293,497 shs$11.33 million04/25/2024$0.81$0.83+2.95%$0.84$0.78165,926 shs$11.08 million04/24/2024$0.95$0.81-14.59%$0.97$0.80429,071 shs$10.76 million04/23/2024$0.95$0.95$0.99$0.94110,041 shs$12.60 million04/22/2024$1.14$0.95-17.11%$1.15$0.94579,868 shs$12.60 million04/19/2024$1.17$1.14-2.56%$1.23$1.10110,484 shs$15.20 million04/18/2024$1.23$1.17-4.88%$1.27$1.17109,327 shs$15.60 million04/17/2024$1.26$1.23-2.38%$1.28$1.2336,612 shs$16.40 million04/16/2024$1.23$1.26+2.44%$1.29$1.2252,987 shs$16.80 million04/15/2024$1.32$1.23-6.82%$1.32$1.2357,963 shs$16.40 million04/12/2024$1.35$1.32-2.22%$1.41$1.3269,684 shs$17.60 million04/11/2024$1.41$1.35-4.26%$1.44$1.3528,609 shs$18.00 million04/10/2024$1.41$1.41$1.42$1.21108,833 shs$18.80 million04/09/2024$1.41$1.41$1.45$1.3821,989 shs$18.80 million04/08/2024$1.40$1.41+0.71%$1.50$1.4069,860 shs$18.79 million04/05/2024$1.48$1.40-5.41%$1.48$1.4024,601 shs$18.66 million04/04/2024$1.48$1.48$1.49$1.4319,775 shs$19.73 million04/03/2024$1.46$1.48+1.37%$1.49$1.3929,564 shs$19.73 million04/02/2024$1.43$1.46+2.10%$1.46$1.3750,176 shs$19.46 million04/01/2024$1.39$1.43+2.88%$1.44$1.3546,459 shs$19.06 million03/29/2024$1.39$1.39$1.43$1.3759,594 shs$18.53 million03/28/2024$1.37$1.39+1.46%$1.43$1.3755,336 shs$18.53 million03/27/2024$1.33$1.37+3.01%$1.38$1.3424,550 shs$18.26 million03/26/2024$1.38$1.33-3.62%$1.46$1.3336,784 shs$17.73 million03/25/2024$1.35$1.38+2.22%$1.41$1.3321,569 shs$18.40 million03/22/2024$1.42$1.35-4.93%$1.40$1.3246,035 shs$18.00 million03/21/2024$1.30$1.42+9.23%$1.43$1.28129,142 shs$18.93 million03/20/2024$1.26$1.30+3.17%$1.30$1.2644,842 shs$17.33 million03/19/2024$1.27$1.26-0.79%$1.30$1.2623,934 shs$16.80 million03/18/2024$1.25$1.27+1.60%$1.30$1.2446,839 shs$16.93 million03/15/2024$1.25$1.25$1.31$1.2547,113 shs$16.66 million03/14/2024$1.27$1.25-1.57%$1.30$1.2450,149 shs$16.66 millionThis 1 Biotech Stock has been shocking the markets (Ad)Save the Date: BioStem's 2024 Q1 Call Coming Up!Sign Up for the Live Broadcast here03/13/2024$1.32$1.27-3.79%$1.37$1.2680,275 shs$16.93 million03/12/2024$1.28$1.32+3.13%$1.36$1.2974,049 shs$17.60 million03/11/2024$1.34$1.28-4.48%$1.36$1.2853,634 shs$17.06 million03/08/2024$1.32$1.34+1.52%$1.37$1.3160,423 shs$17.86 million03/07/2024$1.29$1.32+2.33%$1.37$1.27127,192 shs$17.60 million03/06/2024$1.29$1.29$1.36$1.27146,364 shs$17.20 million03/05/2024$1.29$1.29$1.39$1.25147,610 shs$17.20 million03/04/2024$1.29$1.29$1.31$1.24102,836 shs$17.19 million03/01/2024$1.32$1.29-2.27%$1.35$1.2965,227 shs$17.20 million02/29/2024$1.30$1.32+1.54%$1.36$1.26167,271 shs$17.59 million02/28/2024$1.30$1.30$1.33$1.21163,220 shs$17.33 million02/27/2024$1.36$1.30-4.41%$1.38$1.28162,995 shs$17.33 million02/26/2024$1.41$1.36-3.55%$1.41$1.33139,280 shs$18.13 million02/23/2024$1.40$1.41+0.71%$1.46$1.38107,440 shs$18.80 million02/22/2024$1.40$1.40$1.45$1.37152,929 shs$18.66 million02/21/2024$1.46$1.40-4.11%$1.44$1.37183,430 shs$18.66 million02/20/2024$1.54$1.46-5.19%$1.48$1.35323,055 shs$19.46 million02/19/2024$1.54$1.54$1.65$1.45494,200 shs$20.53 million02/16/2024$1.65$1.54-6.67%$1.65$1.45492,301 shs$19.80 million02/15/2024$2.35$1.65-29.79%$1.94$1.571.64 million shs$21.22 million02/14/2024$1.55$2.35+51.61%$3.93$2.1132.67 million shs$30.22 million02/13/2024$1.50$1.55+3.33%$1.62$1.5371,091 shs$19.93 million02/12/2024$1.47$1.50+2.04%$1.54$1.4735,868 shs$19.29 million02/09/2024$1.43$1.47+2.80%$1.53$1.4126,492 shs$18.90 million02/08/2024$1.44$1.43-0.69%$1.48$1.4030,053 shs$18.39 million02/07/2024$1.51$1.44-4.32%$1.55$1.4254,317 shs$18.52 million Related Companies: Charles & Colvard, Ltd. Stock Price Chart The Dixie Group Stock Price Chart Chicken Soup for the Soul Entertainment Stock Price Chart Visionary Stock Price Chart Barnes & Noble Education Stock Price Chart Super League Enterprise Stock Price Chart Dogness (International) Stock Price Chart InnSuites Hospitality Trust Stock Price Chart Northann Stock Price Chart Salem Media Group Stock Price Chart Receive CNVS Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Cineverse and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:CNVS) was last updated on 5/9/2024 by MarketBeat.com Staff From Our PartnersTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaThis 1 Biotech Stock has been shocking the marketsHuge AlertsExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsUrgent Nvidia WarningAltimetry348 million Americans lives to END as we know it?The Oxford ClubThe A.I. story nobody is telling you (Read ASAP)TradeSmith Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cineverse Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.